EndoArt implant for chronic corneal swelling
Part of Eyes & vision clinical trials.
This trial tests an artificial inner corneal layer (EndoArt) for people with long-term corneal swelling who've had multiple failed corneal transplants and cannot have another. It aims to improve vision and reduce discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 85 years old.
- You must have had corneal swelling for at least 3 months and at least 3 failed corneal transplants (a specific type called EK or PK).
- You cannot be a good candidate for any other form of corneal transplant.
- Your cornea must be a certain thickness (measured by a special test) and you must not have a natural lens in the treated eye (you need an artificial lens implant).
- Your vision in the treated eye must be poor (between 20/63 and hand motion), and your other eye must have better vision.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This trial tests a new treatment for people with corneal swelling that needs surgery. It helps replace the inner layer of the cornea to improve vision.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This study looks at a specific type of cornea transplant (called endothelial lamellar transplant) for people with Fuchs disease or other causes of corneal swelling that affect vision. It aims to see whether this surgical approach improves outcomes and quality of life after surgery.
This Phase 1 study tests whether EO2002 eye drops are safe and well tolerated in people with painful corneal swelling caused by the cornea’s inner lining not working well. It focuses on safety first, but your eye symptoms and vision may be monitored to see how you respond.
This study tests whether adding a special growth factor solution to the fluid used during corneal transplant surgery helps the transplant heal better. It is for patients undergoing a specific type of corneal transplant called DSEK or DMEK.
Hear when a new Corneal Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.